MedPath

To compare effectiveness of dexmeditomidine versus nalbuphine for pain relief in spinal anaesthesia after lower limb surgeries

Phase 2
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/08/056624
Lead Sponsor
Sri Guru Ram Das Institute of Medical Sciences and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients who are consenting for the study

2. Patients undergoing lower limb surgeries

3. American Society of Anesthesiology (ASA) Grade I and II

Exclusion Criteria

1. Contraindications to regional anaesthesia such as anatomic disorders of spine, shock, coagulation and bleeding disorders, local site infections.

2. Patients with hypersensitivity to study drugs

3. Pregnant female

4. Patients with the history of neuropsychiatric problems

5. Patients with communication problems that will not able to understand visual analogue scale (VAS).

6.Patients refusing for consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Post-operative analgesia with dexmedetomidine & nalbuphine <br/ ><br>as adjuvants combined with 0.5 percent hyperbaric levobupivacaine in spinal anesthesia.Timepoint: till 24 hours
Secondary Outcome Measures
NameTimeMethod
To evaluate dexmedetomidine & nalbuphine in terms of onset, duration of sensory and motor block, postoperative analgesic effect, sedation score, side effects of study drugsTimepoint: till 24 hours
© Copyright 2025. All Rights Reserved by MedPath